Article Details

Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients ...

Retrieved on: 2021-04-30 16:41:15

Tags for this article:

Click the tags to see associated articles and topics

Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients .... View article details on hiswai:

Excerpt

The Ventana MMR RxDx Panel has received FDA approval for advanced or recurrent endometrial cancer patients. To access this subscriber-only ...

Article found on: cancerletter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up